Bromocriptine use is associated with decreased smoking rates.
Dopaminergic transmission in the central nervous system is thought to underlie addictive behaviours, including smoking. One effective smoking cessation drug, bupropion, enhances dopaminergic transmission; conversely, antipsychotic drugs, which are dopamine antagonists, are associated with increased...
Principais autores: | Murphy, M, Hey, K, Johnstone, E, Munafo, M, Walton, R, Willis, B, Harrison, P |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2002
|
Registros relacionados
-
Association of the mu-opioid receptor gene with smoking cessation.
por: Munafò, MR, et al.
Publicado em: (2007) -
The genetic basis for smoking behavior: a systematic review and meta-analysis.
por: Munafò, M, et al.
Publicado em: (2004) -
Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial.
por: Johnstone, E, et al.
Publicado em: (2007) -
Association of COMT Val108/158Met genotype with smoking cessation.
por: Munafò, MR, et al.
Publicado em: (2008) -
Central Hyperthermia Treated with Bromocriptine
por: P. Natteru, et al.
Publicado em: (2017-01-01)